- •Contents
- •Introduction
- •Contributors
- •ROLE OF BIOPSY
- •DIRECTED TREATMENTS OF DISTINCT ORBITAL INFLAMMATIONS
- •ABSTRACT
- •ACKNOWLEDGEMENTS
- •5 Future and Emerging Treatments for Microbial Infections
- •MICROBIOLOGIC DIAGNOSIS
- •EMERGING ANTIBIOTIC RESISTANCE
- •HISTORICAL PERSPECTIVE
- •CURRENT APPROACH
- •FUTURE DIRECTIONS
- •7 Non-Hodgkin’s Lymphoma
- •INCIDENCE AND EPIDEMIOLOGY
- •ETIOLOGY AND RISK FACTORS
- •DIAGNOSIS, CLASSIFICATION, AND STAGING
- •TREATMENT
- •ABSTRACT
- •INTRODUCTION
- •STEPS TOWARD TUMOR SPECIFIC THERAPY
- •CANCER SPECIFIC MOLECULAR TARGETS
- •DNA ARRAY ANALYSIS
- •WHICH MOLECULAR TARGETS?
- •CONCLUSIONS
- •10 Malignant Lacrimal Gland Tumors
- •THERAPEUTIC RECOMMENDATIONS
- •SPHENOID WING MENINGIOMAS
- •Location
- •PRESENTING SIGNS AND SYMPTOMS
- •RADIOGRAPHIC IMAGING
- •ULTRASOUND
- •HISTOPATHOLOGY
- •TREATMENT AND PROGNOSIS
- •13 Stereotactic Radiotherapy for Optic Nerve and Meningeal Lesions
- •BACKGROUND
- •DEFINITIONS
- •Precise Immobilization
- •Precise Tumor Localization
- •Conformal Treatment Planning and Delivery
- •FUTURE DEVELOPMENTS
- •SUMMARY
- •ABSTRACT
- •INTRODUCTION
- •ABSTRACT
- •INTRODUCTION
- •Enzyme-Linked Immunosorbent Assay (ELISA)
- •Prospective Study of Graves’ Disease Patients
- •DISCUSSION
- •ACKNOWLEDGEMENTS
- •ORBITAL FIBROBLASTS DISPLAY CELL-SURFACE CD40 AND RESPOND TO CD154
- •CONCLUSIONS
- •ACKNOWLEDGEMENTS
- •INTRODUCTION
- •Retina, RPE, and Choroid
- •Optic Nerve
- •ACKNOWLEDGMENT
- •INTRODUCTION
- •METHODS
- •Historical Features
- •Tempo of Disease Onset
- •Clinical Features
- •DISCUSSION
- •19 Prognostic Factors
- •PREVENTION OF GRAVES’ OPHTHALMOPATHY BY EARLIER DIAGNOSIS AND TREATMENT OF GRAVES’ HYPERTHYROIDISM?
- •CLINICAL ACTIVITY SCORE
- •ORBITAL ECHOGRAPHY
- •ORBITAL OCTREOSCAN
- •ORBITAL MAGNETIC RESONANCE IMAGING
- •URINARY GLYCOSAMINOGLYCANS
- •SERUM CYTOKINES
- •CONCLUSION
- •BACKGROUND
- •VISA CLASSIFICATION
- •Strabismus
- •Appearance=Exposure
- •DISCUSSION
- •INTRODUCTION
- •NONSEVERE GRAVES’ OPHTHALMOPATHY
- •SEVERE GRAVES’ OPHTHALMOPATHY
- •Glucocorticoids
- •Orbital Radiotherapy
- •Immunosuppressive Drugs
- •Plasmapheresis
- •Somatostatin Analogues
- •Intravenous Immunoglobulins
- •Antioxidants
- •Cytokine Antagonists
- •Colchicine
- •INTRODUCTION
- •STABLE ORBITOPATHY
- •Preferred Decompression Techniques
- •EYE MUSCLE SURGERY
- •LID PROCEDURES
- •PATHOPHYSIOLOGY OF THE DISEASE
- •MEDICAL THERAPY
- •IMPROVEMENTS IN ORBITAL DECOMPRESSION
- •IMPROVEMENTS IN EYELID SURGERY
- •STRABISMUS SURGERY
- •Michael Kazim
- •John Kennerdell
- •Daphne Khoo
- •Claudio Marcocci
- •Jack Rootman
- •Wilmar Wiersinga
- •Answer
- •Question 1 (continued)
- •Answer
- •Question 2 (from M. Potts)
- •Answer
- •Question 2 (continued)
- •Question 3
- •Answer
- •Question 3 (continued)
- •Answer
- •Question 3 (continued)
- •Answer
- •Question 3 (continued)
- •Answer
- •Question 4 (from M. Mourits)
- •Answer
- •Question 5 (from F. Buffam)
- •Answer
- •Question 6 (from F. Buffam)
- •Answer
- •Question 7 (from P. Dolman)
- •Answer
- •INTRODUCTION
- •CLINICAL MANIFESTATIONS OF DVVMs
- •INVESTIGATION OF DVVMs
- •FUTURE CONSIDERATIONS
- •CONCLUSION
- •INTRODUCTION
- •CAROTID-CAVERNOUS SINUS FISTULAS
- •ARTERIOVENOUS MALFORMATIONS
- •DISTENSIBLE VENOUS ANOMALIES
- •PREOPERATIVE EMBOLIZATION OF TUMORS
- •ANEURYSMS
- •FUTURE DIRECTIONS
- •ABSTRACT
- •INTRODUCTION
- •TECHNOLOGICAL ADVANCEMENTS
- •Advances in Medical Imaging
- •Virtual Reality Surgical Simulation
- •Surgical Robotics
- •HUMAN BODY MODELS
- •FUTURE COMPUTER-AIDED ORBITAL SURGERY
- •SUMMARY
- •ACKNOWLEDGMENTS
- •30 The Future of Orbital Surgery
- •Index
Vascular Intervention
27
A New Technique in Managing
Distensible Venous Vascular
Malformations of the Orbit
THOMAS R. MAROTTA and |
JACK ROOTMAN |
DOUGLAS A. GRAEB |
Department of Ophthalmology and |
|
|
Diagnostic and Therapeutic |
Visual Sciences, and Department of |
Neuroradiology, St. Michael’s Hospital, |
Pathology, University of British |
University of Toronto, Toronto, |
Columbia, Vancouver General |
Ontario, Canada |
Hospital, Vancouver, |
|
British Columbia, Canada |
INTRODUCTION
Multidisciplinary approaches to human diseases arise out of limitations in treating complex disorders with methods that fall into single areas of expertise. With combined expertise, otherwise difficult lesions become more easily managed. We have been able to apply interventional neuroradiologic techniques to a variety of vascular lesions of the orbit (1,2) to successfully treat what might otherwise be considered untreatable.
321
322 |
Marotta et al. |
This presentation will outline the technique that we use in treating selected patients with distensible venous vascular malformations (DVVMs) of the orbit (orbital varices).
CLASSIFICATION OF ORBITAL VASCULAR
LESIONS
An exhaustive discussion of this classification is beyond the scope of this presentation but is discussed in detail elsewhere (2,3). The overall concept distinguishes ‘‘new growth’’ from ‘‘malformation’’ and emphasizes the difference between an acquired arteriovenous shunt or fistula (i.e., carotid-cavernous fistula) and other vascular malformations. Vascular malformations can then be subdivided based at least in part on flow into noflow, venous flow, and arterial flow lesions. A lymphatic vascular malformation would typify the no-flow lesion, and arteriovenous malformation the arterial flow lesion. Venous flow lesions include distensible venous, nondistensible venous, and combined nondistensible venous–lymphatic vascular malformations. It is the DVVMs that enlarge with Valsalva maneuver or bending for which the combined technique of direct puncture embolization followed by surgical excision has been used.
DVVMs may be superficial, deep (posterior to the globe), or a combination of these. Their involvement may extend beyond the boundaries of the orbit to include the face, paranasal sinuses, or intracranially; these are called complex venous malformations (Fig. 1).
ANATOMY OF ORBITAL REGION VENOUS
STRUCTURES AND RELATIONSHIP WITH
DVVMs
The orbital venous system has a significant outflow connection via the superior and inferior orbital veins to the cavernous sinus, venous plexus of the pterygopalatine fossa, and supratrochlear and angular veins of the face.
The relationship of DVVMs to normal veins of the orbit and its neighboring structures is variable but at least in part
Distensible Venous Vascular Malformations |
323 |
Figure 1 Coronal CT (A) and MR (B) imaging and lateral (C) and frontal (D) views from a direct injection show a complex DVVM extending from superficial to deep in the orbit and also intracranially through a bony defect in the roof of the orbit. (Borrowed with permission from Ref. 2.)
predictable by the location of the malformation. The distensibility of these lesions indicates relatively large functioning connections with the normal venous system. When the pressure in the venous system is elevated, it is reflected back stream into the malformation, which distends. Depending on venous connections, these DVVMs can on occasion be visualized by indirect orbital venographic techniques. Those connected to the superior ophthalmic vein may be seen this way (Fig. 2). However, the best means to delineate specific
324 |
Marotta et al. |
Figure 2 Direct venogram demonstrates a venous orbital malformation. This is characterized by an ectatic venous outflow channel that is part of the superior ophthalmic vein. (Borrowed with permission from Ref. 3.)
features of a DVVM and its connections is by direct intralesional injection. The DVVMs can be relatively simple ectatic areas that merge with adjacent normal orbital veins (Fig. 3B), or more complex malformations with multiple channels and saccular areas that flow into dysplastic venous networks to the pterygopalatine fossa or the superior or inferior ophthalmic venous systems (Figs. 3 and 4).
CLINICAL MANIFESTATIONS OF DVVMs
Generally, DVVMs do not warrant treatment. Superficial lesions might be seen as dark, tortuous epibulbar varices or as subcutaneous lid masses (Fig. 5). Deep lesions will be less
